Edward Fang
- Infectious Diseases top 2%
- Clinical Biochemistry top 0.5%
- Pharmacology top 5%
- Public Health, Environmental and Occupational Health top 5%
- Molecular Biology
- Co-authors
- Philippe ProkocimerCarisa De AndaAnita DasPurvi MehraG. Ralph CoreySonia L. MinassianGregory J. MoranThomas P. Lodise
- Topics
- Antimicrobial Resistance in Staphylococcus (18 papers)Bacterial Identification and Susceptibility Testing (8 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)
- Partner nations
- United StatesArgentinaCanada
In The Last Decade
Edward Fang
26 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 862
- Clinical Biochemistry 482
- Pharmacology 346
- Public Health, Environmental and Occupational Health 295
- Molecular Biology 231
Countries citing papers authored by Edward Fang
This map shows the geographic impact of Edward Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Fang more than expected).
Fields of papers citing papers by Edward Fang
This network shows the impact of papers produced by Edward Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Fang. The network helps show where Edward Fang may publish in the future.
Co-authorship network of co-authors of Edward Fang
This figure shows the co-authorship network connecting the top 25 collaborators of Edward Fang. A scholar is included among the top collaborators of Edward Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Fang. Edward Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 19 | |
| 6 | 3 | |
| 7 | 13 | |
| 8 | 16 | |
| 9 | 49 | |
| 10 | 241 | |
| 11 | 62 | |
| 12 | 120 | |
| 13 | 39 | |
| 14 | 13 | |
| 15 | 283 | |
| 16 | 55 | |
| 17 | Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections | 3 |
| 18 | 126 | |
| 19 | 89 | |
| 20 | Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice. | 21 |
About Edward Fang
Edward Fang is a scholar working on Clinical Biochemistry, Infectious Diseases and Molecular Medicine, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (18 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Clinical Biochemistry (482 citations), Applied Microbiology and Biotechnology (106 citations) and Infectious Diseases (862 citations). Edward Fang has collaborated with scholars based in United States, Argentina and Canada. Frequent co-authors include Philippe Prokocimer, Carisa De Anda, Anita Das, Purvi Mehra, G. Ralph Corey, Sonia L. Minassian, Gregory J. Moran, Thomas P. Lodise, Shawn D. Flanagan and Shawn Flanagan. Their work appears in journals such as JAMA, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.